Osteoarthritis Therapeutics Market (By Drug Type: Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids; By Anatomy: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Small Joint Osteoarthritis; By Route of Administration: Parenteral Route, Topical Route, Oral Route; By Purchasing Pattern: Prescription Drugs, Over-the-Counter Drugs; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027

CHAPTER 1. Industry Overview of Osteoarthritis Therapeutics
1.1. Definition and Scope
1.1.1. Definition of Osteoarthritis Therapeutics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Osteoarthritis Therapeutics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Osteoarthritis Therapeutics Market By Drug Type
1.2.3. Osteoarthritis Therapeutics Market By Anatomy
1.2.4. Osteoarthritis Therapeutics Market By Route of Administration
1.2.5. Osteoarthritis Therapeutics Market By Purchasing Pattern
1.2.6. Osteoarthritis Therapeutics Market By Distribution Channel
1.2.7. Osteoarthritis Therapeutics Market by Regions

CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Cost Structure Analysis
3.5.1. Price Trend of Key Raw Materials
3.5.2. Raw Material Suppliers
3.5.3. Proportion of Manufacturing Cost Structure
3.5.3.1. Raw Material
3.5.3.2. Labor Cost
3.5.3.3. Manufacturing Expense
3.6. Regulatory Compliance
3.7. Competitive Landscape, 2019
3.7.1. Player Positioning Analysis
3.7.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Osteoarthritis Therapeutics Market By Drug Type
4.1. Introduction
4.2. Osteoarthritis Therapeutics Revenue By Drug Type
4.2.1. Osteoarthritis Therapeutics Revenue (US$ Mn) and Forecast, By Drug Type, 2016-2027
4.2.2. Viscosupplementation Agents
4.2.2.1. Viscosupplementation Agents Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Nonsteroidal Anti-inflammatory Drugs
4.2.3.1. Nonsteroidal Anti-inflammatory Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.1.1. Naproxen
4.2.3.1.1.1. Naproxen Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.1.2. Aspirin
4.2.3.1.2.1. Aspirin Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.1.3. Diclofenac
4.2.3.1.3.1. Diclofenac Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.1.4. Ibuprofen
4.2.3.1.4.1. Ibuprofen Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.1.5. Other NSAIDs
4.2.3.1.5.1. Other NSAIDs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Analgesics
4.2.4.1. Analgesics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4.1.1. Duloxetine
4.2.4.1.1.1. Duloxetine Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4.1.2. Acetaminophen
4.2.4.1.2.1. Acetaminophen Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Corticosteroids
4.2.5.1. Corticosteroids Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 5. Osteoarthritis Therapeutics Market Revenue By Anatomy
5.1. Introduction
5.2. Osteoarthritis Therapeutics Revenue (US$ Mn) By Anatomy
5.2.1. Osteoarthritis Therapeutics Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
5.2.2. Knee Osteoarthritis
5.2.2.1. Knee Osteoarthritis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Hip Osteoarthritis
5.2.3.1. Hip Osteoarthritis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Hand Osteoarthritis
5.2.4.1. Hand Osteoarthritis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Small Joint Osteoarthritis
5.2.5.1. Small Joint Osteoarthritis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 6. Osteoarthritis Therapeutics Market By Route of Administration
6.1. Introduction
6.2. Osteoarthritis Therapeutics Revenue (US$ Mn) By Route of Administration
6.2.1. Osteoarthritis Therapeutics Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
6.2.2. Parenteral Route
6.2.2.1. Parenteral Route Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Topical Route
6.2.3.1. Topical Route Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Oral Route
6.2.4.1. Oral Route Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 7. Osteoarthritis Therapeutics Market By Purchasing Pattern
7.1. Introduction
7.2. Osteoarthritis Therapeutics Revenue (US$) By Purchasing Pattern
7.2.1. Osteoarthritis Therapeutics Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
7.3. Prescription Drugs
7.3.1. Prescription Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.4. Over-the-Counter Drugs
7.4.1. Over-the-Counter Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 8. Osteoarthritis Therapeutics Market By Distribution Channel
8.1. Introduction
8.2. Osteoarthritis Therapeutics Revenue (US$) By Distribution Channel
8.2.1. Osteoarthritis Therapeutics Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
8.3. Hospital Pharmacies
8.3.1. Hospital Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
8.4. Retail Pharmacies
8.4.1. Retail Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
8.5. Online Pharmacies
8.5.1. Online Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 9. North America Osteoarthritis Therapeutics Market By Country
9.1. North America Osteoarthritis Therapeutics Overview
9.2. U.S.
9.2.1. U.S. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
9.2.2. U.S. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
9.2.3. U.S. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.2.4. U.S. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
9.2.5. U.S. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.3. Canada
9.3.1. Canada Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
9.3.2. Canada Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
9.3.3. Canada Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.3.4. Canada Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
9.3.5. Canada Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.4. North America PEST Analysis

CHAPTER 10. Europe Osteoarthritis Therapeutics Market By Country
10.1. Europe Osteoarthritis Therapeutics Market Overview
10.2. U.K.
10.2.1. U.K. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
10.2.2. U.K. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
10.2.3. U.K. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
10.2.4. U.K. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
10.2.5. U.K. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.3. Germany
10.3.1. Germany Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
10.3.2. Germany Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
10.3.3. Germany Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
10.3.4. Germany Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
10.3.5. Germany Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.4. France
10.4.1. France Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
10.4.2. France Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
10.4.3. France Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
10.4.4. France Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
10.4.5. France Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.5. Spain
10.5.1. Spain Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
10.5.2. Spain Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
10.5.3. Spain Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
10.5.4. Spain Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
10.5.5. Spain Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.6. Rest of Europe
10.6.1. Rest of Europe Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
10.6.2. Rest of Europe Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
10.6.3. Rest of Europe Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
10.6.4. Rest of Europe Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
10.6.5. Rest of Europe Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.7. Europe PEST Analysis

CHAPTER 11. Asia Pacific Osteoarthritis Therapeutics Market By Country
11.1. Asia Pacific Osteoarthritis Therapeutics Market Overview
11.2. China
11.2.1. China Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
11.2.2. China Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
11.2.3. China Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.2.4. China Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
11.2.5. China Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.3. Japan
11.3.1. Japan Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
11.3.2. Japan Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
11.3.3. Japan Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.3.4. Japan Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
11.3.5. Japan Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.4. India
11.4.1. India Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
11.4.2. India Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
11.4.3. India Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.4.4. India Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
11.4.5. India Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.5. Australia
11.5.1. Australia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
11.5.2. Australia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
11.5.3. Australia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.5.4. Australia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
11.5.5. Australia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.6. South Korea
11.6.1. South Korea Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
11.6.2. South Korea Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
11.6.3. South Korea Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.6.4. South Korea Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
11.6.5. South Korea Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
11.7.2. Rest of Asia-Pacific Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
11.7.3. Rest of Asia-Pacific Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.7.4. Rest of Asia-Pacific Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
11.7.5. Rest of Asia-Pacific Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.8. Asia Pacific PEST Analysis

CHAPTER 12. Latin America Osteoarthritis Therapeutics Market By Country
12.1. Latin America Osteoarthritis Therapeutics Market Overview
12.2. Brazil
12.2.1. Brazil Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
12.2.2. Brazil Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
12.2.3. Brazil Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
12.2.4. Brazil Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
12.2.5. Brazil Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
12.3. Mexico
12.3.1. Mexico Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
12.3.2. Mexico Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
12.3.3. Mexico Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
12.3.4. Mexico Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
12.3.5. Mexico Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
12.4. Rest of Latin America
12.4.1. Rest of Latin America Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
12.4.2. Rest of Latin America Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
12.4.3. Rest of Latin America Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
12.4.4. Rest of Latin America Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
12.4.5. Rest of Latin America Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027

CHAPTER 13. Middle East & Africa Osteoarthritis Therapeutics Market By Country
13.1. Middle East & Africa Osteoarthritis Therapeutics Market Overview
13.2. Saudi Arabia
13.2.1. Saudi Arabia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
13.2.2. Saudi Arabia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
13.2.3. Saudi Arabia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
13.2.4. Saudi Arabia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
13.2.5. Saudi Arabia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
13.3. UAE
13.3.1. UAE Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
13.3.2. UAE Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
13.3.3. UAE Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
13.3.4. UAE Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
13.3.5. UAE Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
13.4.2. Rest of Middle East & Africa Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
13.4.3. Rest of Middle East & Africa Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
13.4.4. Rest of Middle East & Africa Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
13.4.5. Rest of Middle East & Africa Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027

CHAPTER 14. Player Analysis Of Osteoarthritis Therapeutics
14.1. Osteoarthritis Therapeutics Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Osteoarthritis Therapeutics Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 15. Company Profile
15.1. Abbott Laboratories
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (US$ Mn), 2019
15.1.3.2. Abbott Laboratories 2019 Osteoarthritis Therapeutics Business Regional Distribution
15.1.4. Product/ Service and Specification
15.1.5. Recent Developments & Business Strategy
15.1.6. Manufacturing Plant Footprint Analysis
15.2. Anika Therapeutics Inc.
15.3. Bayer Aktiengesellschaft
15.4. Eli Lilly Company
15.5. Flexion Therapeutics Inc.
15.6. GlaxoSmithKline Plc
15.7. Horizon Therapeutics Plc
15.8. Johnson & Johnson Inc.
15.9. Novartis AG
15.10. Pfizer Inc.
15.11. Sanofi S.A
15.12. Others